mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
AZD-2281 |
FIMM |
pan-cancer |
AAC |
-0.41 |
0.02 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.02 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |